Compile Data Set for Download or QSAR
maximum 50k data
Found 68 of ec50 for UniProtKB: P26664
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241839(US9416139, 17)
Affinity DataEC50:  0.0230nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241851(US9416139, 29)
Affinity DataEC50:  0.0610nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241832(US9416139, 10 | US9416139, 11)
Affinity DataEC50:  0.0680nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241855(US9416139, 33)
Affinity DataEC50:  0.0780nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241827(US9416139, 5)
Affinity DataEC50:  0.0780nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241843(US9416139, 21)
Affinity DataEC50:  0.0800nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241838(US9416139, 16)
Affinity DataEC50:  0.0890nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241826(US9416139, 4)
Affinity DataEC50:  0.0890nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241828(US9416139, 6)
Affinity DataEC50:  0.109nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241837(US9416139, 15)
Affinity DataEC50:  0.206nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241829(US9416139, 7)
Affinity DataEC50:  0.210nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241845(US9416139, 23)
Affinity DataEC50:  0.310nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241840(US9416139, 18)
Affinity DataEC50:  0.326nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241852(US9416139, 30)
Affinity DataEC50:  0.336nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241834(US9416139, 12)
Affinity DataEC50:  0.380nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241858(US9416139, 36)
Affinity DataEC50:  0.438nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241831(US9416139, 9)
Affinity DataEC50:  0.439nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241846(US9416139, 24)
Affinity DataEC50:  0.475nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241825(US9416139, 3)
Affinity DataEC50:  0.537nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241844(US9416139, 22)
Affinity DataEC50:  0.561nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241856(US9416139, 34)
Affinity DataEC50:  0.641nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241848(US9416139, 26)
Affinity DataEC50:  0.727nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241823(US9416139, 1 | US9416139, 2)
Affinity DataEC50:  0.760nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241847(US9416139, 25)
Affinity DataEC50:  0.829nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241836(US9416139, 14)
Affinity DataEC50:  0.884nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241830(US9416139, 8)
Affinity DataEC50:  0.982nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241850(US9416139, 28)
Affinity DataEC50:  1.10nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241832(US9416139, 10 | US9416139, 11)
Affinity DataEC50:  1.27nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241823(US9416139, 1 | US9416139, 2)
Affinity DataEC50:  1.28nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241849(US9416139, 27)
Affinity DataEC50:  1.53nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241835(US9416139, 13)
Affinity DataEC50:  2.07nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241842(US9416139, 20)
Affinity DataEC50:  3.67nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241841(US9416139, 19)
Affinity DataEC50:  4.77nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241853(US9416139, 31)
Affinity DataEC50:  5.87nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241854(US9416139, 32)
Affinity DataEC50:  10.3nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1973-2420](Hepatitis C virus genotype 1a (HCV))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241857(US9416139, 35)
Affinity DataEC50:  10.6nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287989(US10087167, Compound 3003)
Affinity DataEC50:  25.2nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288003(US10087167, Compound 4012)
Affinity DataEC50:  27.1nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288011(US10087167, Compound 4020)
Affinity DataEC50:  45nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287983(US10087167, Compound 1001)
Affinity DataEC50:  45.4nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288015(US10087167, Compound 4024)
Affinity DataEC50:  76.5nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288007(US10087167, Compound 4016)
Affinity DataEC50:  84.8nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287998(US10087167, Compound 4007)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287995(US10087167, Compound 4005)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287992(US10087167, Compound 4003)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287991(US10087167, Compound 4002)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287988(US10087167, Compound 3002)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287986(US10087167, Compound 3001)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288002(US10087167, Compound 4011)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288017(US10087167, Compound 4026)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 68 total ) | Next | Last >>
Jump to: